🔴 Citius Pharmaceuticals is trading 5% down with no clear catalyst identified

Citius Pharmaceuticals is trading 5.10% down at $0.43, with no verified company-specific announcement or clear catalyst identified for the October 27 decline.

• Citius Oncology reported preliminary LYMPHIR wholesaler shipments up 120% on October 26.
• The positive update was tied to the prior session’s gain and does not establish a reason for the subsequent decline; available evidence is insufficient to identify a cause.